Target intelligence / Profile preview

Botulinum neurotoxin type F (None)

Target: None
Molecular classification: Protein toxin, Neurotoxin, Metalloprotease

Overview

Botulinum neurotoxin type F is a structurally complex bacterial protein that acts as a zinc metalloprotease targeting neuronal SNARE proteins essential for neurotransmitter release. Its action results in rapid-onset flaccid paralysis characteristic of botulism when ingested or introduced into humans or animals. While rare compared to other serotypes like A or B, its clinical significance lies in its extreme potency.

Mechanism of action

Cleaves VAMP/synaptobrevin SNARE proteins, preventing acetylcholine release.

Biological functions

Neurotransmitter release inhibitionMuscle paralysis

Disease associations

Botulism

Safety considerations

High potencyCauses flaccid paralysisPotential biological threat agent

Interacting drugs

Antitoxin (BoNT/F)

Beyond the preview

Go deeper on Botulinum neurotoxin type F (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Botulinum neurotoxin type F (None).

Explore the full profile